Рак пищевода. Роль радиотерапии в проведении специального лечения (практические аспекты)

Автор: Паньшин Георгий Александрович

Журнал: Вестник Российского научного центра рентгенорадиологии Минздрава России @vestnik-rncrr

Статья в выпуске: 2 т.17, 2017 года.

Бесплатный доступ

В статье кратко анализируется современное состояние вопроса по проблеме рака пищевода, оценивается роль радиотерапии в самостоятельном, комбинированном и комплексном лечении и приводятся практические рекомендации по ее реализации в зависимости от клинической ситуации.

Рак пищевода, радиотерапия, практические рекомендации

Короткий адрес: https://sciup.org/14955547

IDR: 14955547

Список литературы Рак пищевода. Роль радиотерапии в проведении специального лечения (практические аспекты)

Гордеев С.С. American Society of Clinical Oncology (ASCO). Annual Meeting. 2010.
Давыдов М.И., Стилиди И.С. Рак пищевода. 3-е изд., испр. и доп. М. Издательская группа РОНЦ. Практическая медицина. 2007. 392 с.
Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). Под редакцией А.Д. Каприна, В.В. Старинского, Г.В. Петровой. Москва. 2017.
Иншаков Л.Н., Паламарчук Г.Ф., Кузьмин-Крутецкий М.И. Клинико-эндоскопическая диагностика хронических заболеваний и рака пищевода. Учебное издание. Санкт-Петербург. СПбМАПО. 2011. 110 с.
Канаев С.В., Щербаков А.М., Тюряева Е.И. и др. Консервативное лечение местнораспространенного и неоперабельного рака пищевода: Возможности и перспективы. Вопросы онкологии. 2012. Т. 58. N. 2. С. 199-202.
Мерабишвили В.М. Выживаемость онкологических больных. Выпуск второй. Часть 1. Под редакцией проф. Ю.А. Щербука. Санкт-Петербург. 2011. 329 с.
Мерабишвили В.М. Динамика наблюдаемой и относительной выживаемости больных раком пищевода (популяционное исследование). Вопросы онкологии. 2013. Т. 59. N. 2. С. 41-46.
Минимальные клинические рекомендации европейского общества медицинской онкологии (ESMO). Редакторы русского перевода: проф. С.А.Тюляндин, к.м.н. Д.А. Носов; проф. Н.И. Переводчикова. М. Издательская группа РОНЦ им. Н.Н. Блохина РАМН. 2010. 436 с.
Скворцов М.Б., Романовский Д.И. Хирургическое лечение рака средне-и нижнегрудного отделов пищевода (клиническое наблюдение). Бюллетень ВСНЦ СО РАМН. 2010. T. 6. N. 76. Часть 1. С. 99-106.
Стилиди И.С. Рак пищевода. Энциклопедия клинической онкологии. Под ред. М.И. Давыдова. М. ООО «РЛС-2004». 326 с. 11.
Almhanna K., Shridhar R., Meredith K.L. Neoadjuvant or Adjuvant Therapy for Resectable Esophageal Cancer: Is There a Standard of Care. Cancer Control. 2013. V. 20. N. 2. Р. 89 -96.
Apinop C., Puttisak P., Preecha N. A prospective study of combined therapy in esophageal cancer. Hepatogastroenterology. 1994. V. 41. N. 4. P. 391-393.
Arnott S.J., Duncan W., Gignoux M., et al. Preoperative radiotherapy for esophageal carcinoma. Cochrane Database Syst Rev. 2005. V. 19. N. 4. CD001799.
Berger B., Belka C. Evidence-based radiation oncology: oesophagus. 2009. N. 92. N. 2. Р. 276-290.
Bosetti C., Bertuccio P., Levi F., et al. Cancer mortality in the European Union, 1970-2003, with a joinpoint analysis. Ann Oncol. 2008a; V. 19. N. 4. P. 631-640.
Bosetti C., Levi F., Ferlay J., et al. Trends in oesophageal cancer incidence and mortality in Europe. Int. J. Cancer. 2008b. V. 122. P. 1118-1129.
Bosset J.F., Gignoux M., Triboulet J.P., et al. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997. V. 337. N. 3. P. 161-167.
Brewster A.E., Davidson S.E., Makin W.P,. et al. Intraluminal brachytherapy using the high dose rate Microselectron in palliation of carcinoma of esophagus. Clin Oncol (R Coll Radiol). 1995. V. 7. P. 102-105.
Cooper J.S., Guo M.D., Herskovic A., et al. Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA. 1999. V. 281. N. 17. P. 1623-1627.
Edge S., Byrd D., Compton C., et al. AJCC cancer staging manual (7th ed). New York. NY: Springer. 2010.
Engel L.S, Chow W.H., Vaughan T.L., et al. Population attributable risks of esophageal and gastric cancers. J. Natl. Cancer Inst. 2003. V. 95. N. 18. P. 1404-1413.
Esfehani M.H., Mahmoodzadeh H., Omranipour R. Oesophageal perforation during neo-adjuvant brachytherapy for oesophageal squamous cell carcinoma. J Egypt Natl Canc. Inst. 2015. V. 27. N. 1. P. 45-46.
Esophageal cancer: epidemiology, pathogenesis and prevention. Nat. Clin Pract. Gastroenterol Hepatol. 2008. V. 5. N. 9. P. 517-526.
Ferlay J., Shin H.R., Bray F., et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010. V.127. N. 12. P. 2893-2917.
Fiorica F., Di Bona D., Schepis F., et al. Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis. Gut. 2004. V. 53. N. 7. P. 925-930.
Fok M., Sham J.S., Choy D., et al. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery. 1993. V. 113. N. 2. P.138-147.
Gebski V., Burmeister B., Smithers B.M., et al. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol. 2007. V. 8. N. 3. P. 226-234.
Greene F.L., Trotti A., Fritz A.G., et al. New York: Springer-Verlag. 2009. AJCC Cancer Staging Manual. 7th ed.
Halperin E.C., Brady L.W., Perez C.A., Wazer D.E. Perez & Brady's Principles and Practice of Radiation Oncology, 6e. Lippincott Williams & Wilkins. 2013. 1936 p.
Harvey J.C., Fleischman E.H., Belloti J.E., et al. Intracavitary radiation in treatment of advanced esophageal carcinoma. A comparison of high dose rate vs low dose rate brachytherapy. J Surg Oncol 1993. V. 52. N. 2. P. 101-104.
Herskovic A., Martz K., al-Sarraf M., et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med. 1992. V. 326. N. 24. Р. 1593-1598.
Kuwano H., Nishimura Y., Oyama T., et al. Guidelines for Diagnosis and Treatment of Carcinoma of the Esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015. V. 12. P. 1-30.
Huang S.H. Lockwood G. Brierley J., et al. Effect of concurrent high-dose cisplatin chemotherapy and conformal radiotherapy on cervical esophageal cancer survival. Int J Radiat Oncol Biol Phys. 2008. V. 71. N. 3. P. 735-740.
Islami F., Boffetta P., Ren J.S., et al. High-temperature beverages and foods and esophageal cancer risk -a systematic review. Int J Cancer. 2009. V. 125. N. 3. P. 491-524.
Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin. V. 60. N. 5. P. 277-300.
Kamangar F., Chow W.H., Abnet C.C., et al. Environmental causes of esophageal cancer. Gastroenterol. Clin North Am. 2009. V. 38. N. 1. P. 27-57.
Kelsen D.P., Winter K.A., Gunderson L.L., et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol. 2007. V. 25. N. 24. P. 3719-3725.
Le Prise E., Etienne P.L., Meunier B., et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus. Cancer. 1994. V. 73. N. 7. P. 1779-1784.
Lin J., Zeng R., Cao W., et al. Hot beverage and food intake and esophageal cancer in southern China. Asian. Pac J Cancer Prev. 2011. V. 12. N. 9. P. 2189-2192.
Minsky B.D., Neuberg D., Kelsen D.P., et al. Neoadjuvant chemotherapy plus concurrent chemotherapy and high-dose radiation for squamous cell carcinoma of the esophagus: a preliminary analysis of the phase II intergroup trial 0122. J Clin Oncol. 1996. V. 14. N. 1. P. 149-155.
Minsky B.D., Pajak T.F., Ginsberg R.J., et al. INT 0123 (Radiation Therapy Oncology Group 94-05) phase III trial of combined-modality therapy for esophageal cancer: high-dose versus standard-dose radiation therapy. J Clin Oncol. 2002. V. 20. N. 5. P. 1167-1174.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines). Esophageal Cancers and Esophagogastric Junction.Version 3. 2015.
Nygaard K., Hagen S., Hansen H.S., et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer. World J Surg. 1992. V. 16. N. 6. P. 1104-1109.
Okawa T., Dokiya T., Nishio M., et al. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for esophageal cancer in Japan. Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Int J Radiat Oncol Biol Phys.1999. V. 45. N. 3. P. 623-628.
Parkin D.M., Bray F., Ferlay J., et al. Global cancer statistics, 2002. CA. Cancer. J Clin. 2005. V. 55. N. 2. P. 74-108.
Pasquier D., Mirabel X., Adenis A., et al. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2006. V. 65. N. 5. P. 1456-1461.
Sai H., Mitsumori M., Araki N., et al. Long-term results of definitive radiotherapy for stage I esophageal cancer. Int J Radiat Oncol Biol Phys. 2005. V. 62. N. 5. P.1339-1344.
Shridhar R, Almhanna K., Meredith K.L., et al. Radiation Therapy and Esophageal Cancer Cancer. Control. 2013. V. 20. N. 2 P. 92-110.
Siegel R.L., Miller K.D., Jemal A. Cancer statistics, 2016. CA Cancer J Clin. V. 66. N. 1. P. 7-30.
Sjoquist K.M., Burmeister B.H., Smithers B.M., et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 2011. V. 12. N. 7. P. 681-692.
Sur R.K., Singh D.P., Sharma S.C., et al. Radiation therapy of esophageal cancer:Role of high dose rate brachytherapy. Int J Radiat Oncol Biol Phys. 1992. V. 22. N. 5. P. 1043-1046.
Sur R.K., Kochhar R., Negi P.S.,Gupta B.D. High dose rate intralumenal brachytherapy in palliation of esophageal carcinoma. Endocurietherapy/Hyperthermia Oncol. 1994. V. 10. P. 25-29.
Sykes A.J. Radical radiotherapy for carcinoma of the oesophagus: an effective alternative to surgery. Radiotherapy and Oncology. 1998. V. 48. N. 1. Р. 15-21.
Tachimori Y., Ozawa S., Fujishiro M. et al. Comprehensive Registry of Esophageal Cancer in Japan, 2006. Esophagus. 2013. V. 11. P. 21-47.
Teniere P., Hay J.M., Fingerhut А., et al. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet. 1991. V. 173. N. 2. P. 123-130.
Tepper J., Krasna M.J., Niedzwiecki D., et al. Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781. J Clin Oncol. 2008. V. 26. N. 7. P. 1086-1092.
Urba S.G., Orringer M.B., Turrisi A., et al. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol. 2001. V. 19. N. 2. P. 305-313.
Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996. V. 335. N. 7. P. 462-467.
World Health Organization, International Agency for Research on Cancer. GLOBOCAN 2012. Estimated Cancer Incidence. Mortality and Prevalence Worldwide in 2012. . International Agency for Research on Cancer. 2012. http://globocan.iarc.fr.
Wu K.L., Chen G.Y., Xu Z.Y., et al. Tree-dimensial conformal radiation therapy for squamous cell of the esophagus: a prospective phase I/II study. Radiotherapy and Oncology. 2009. N. 93. N. 3. Р. 454-457.
Wu M., Liu A.M, Kampman E., et al. Green tea drinking, high tea temperature and esophageal cancer in high-and low-risk areas of Jiangsu Province, China: a population-based case-control study. Int J Cancer. 2009. V. 124. N. 8. P. 1907-1913.
Yamada K., Murakami M., Okamoto Y., et al. Treatment results of chemoradiotherapy for clinical stage I (T1N0M0) esophageal carcinoma. Int J Radiat Oncol Biol Phys. 2006. V. 64. N. 4. P. 1106-1111.
Yin W. Brachytherapy of carcinoma of the esophagus in China, 1970-1974 and 1982-1984. In: Proc. Remote Afterloading. Brachytherapy Meeting. 1989. P. 34-35.
Zhang Y. Epidemiology of esophageal cancer. World J Gastroenterol. 2013. V. 19. N. 34. P. 5598-5606.

Еще

Статья научная